Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies
New research describes a novel approach whereby SARS-2 antigens were analyzed for conserved sites that may be targeted by broadly neutralizing antibodies that will confer immunity to other Sarbecoviruses.
Cell Reportsdescribes Coronavirus Disease Covid 19 Ars Cov 2 Covid 19 Immune Response Evere Acute Respiratory
Source: news-medical.net